Several analysts have recently updated their ratings and price targets for ANI Pharmaceuticals (NASDAQ: ANIP): 5/20/2023 – ANI Pharmaceuticals was downgraded by analysts at StockNews.com from a 'buy' rating to a 'hold' rating. 5/12/2023 – ANI Pharmaceuticals was upgraded by analysts at StockNews.com from a 'hold' rating to a 'buy' rating. 5/9/2023 – ANI Pharmaceuticals had its price target raised by analysts at Guggenheim from $55.00 to $59.00. 5/9/2023 – ANI Pharmaceuticals had its price target raised by analysts at HC Wainwright from $53.

https://www.dailypolitical.com/2023/05/23/analysts-weekly-ratings-changes-for-ani-pharmaceuticals-anip.html

#dailypolitical